Results 31 to 40 of about 709,580 (281)

A Case Series of Life-Threatening MDMA Poisoning in An Electronic Dance Music Party in Hong Kong [PDF]

Asia Pacific Journal of Medical Toxicology, 2018
Background: MDMA (3,4-methylenedioxymethamphetamine), which is also known as Ecstasy or Molly, is a commonly found abusive agent in Hong Kong. MDMA abuse is widely reported in electronic dance music (EDM) festivals all over the world.
Francis Chu, Anfernee Yim, Sau Wah Ng
doaj   +1 more source

Cyproheptadine in serotonin syndrome: A retrospective study

Journal of Family Medicine and Primary Care
Objective: Serotonin syndrome (SS) is an iatrogenic life-threatening condition caused by serotonergic agents. The treatment for SS involves the administration of a serotonin antagonist (cyproheptadine).
Sanjay Prakash, Harsh Patel, Sunil Kumar, Chetsi S. Shah   +3 more
doaj   +1 more source

Antidepressant Overdose: An Updated Review on Diagnosis and Outcome [PDF]

Zagazig University Medical Journal
Background: Antidepressant drugs are among the most commonly encountered causes of self-poisoning. These drugs include tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin and ...
samah elgendy, Ghada Elmesallamy, Eman Khayal, Raghda Deraz   +3 more
doaj   +1 more source

Methylene Blue Causing Serotonin Syndrome Following Cystocele Repair

Urology Case Reports, 2016
Methylene blue is an intravenously administered agent that may potentiate serotonin syndrome. The usage of methylene blue to evaluate ureters for injuries and patency during urological surgeries is recognized as common practice.
Kailash Kapadia, Felix Cheung, Wai Lee, Richard Thalappillil, F. Barry Florence, Jason Kim   +5 more
doaj   +1 more source

The Pathophysiology of Serotonin Toxicity in Animals and Humans

, 2015
Serotonin toxicity (or serotonin syndrome) has become an increasingly common and important clinical problem in medicine over the last 15 years with the introduction of many new antidepressants that can cause increased levels of serotonin (5-HT) in the ...
Isbister, Geoffrey K, Buckley, Nicholas
core   +1 more source

Serotonin Syndrome with Monotherapy of Low-Dose Sertraline in an Adult Patient with Autism Spectrum Disorder

Case Reports in Psychiatry, 2023
Serotonin syndrome, also known as serotonin toxicity, is associated with increased serotonergic activity in the central and the peripheral nervous system. The symptoms can range from mild to potentially life threatening.
Rohit Madan, Jody Platto, Senthil Rajaram Manoharan, Varun Monga   +3 more
doaj   +1 more source

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones

Frontiers in Pharmacology, 2019
Halogenated derivatives of amphetamine-type stimulants are appearing on the drug market, often with altered pharmacological profile and sometimes different legal status compared to the non-halogenated substances.
Dino Luethi, Melanie Walter, Xun Zhou, Deborah Rudin, Stephan Krähenbühl, Stephan Krähenbühl, Matthias E. Liechti   +6 more
doaj   +1 more source

Conformationally Flexible Dimeric-Serotonin-Based Sensitive and Selective Electrochemical Biosensing Strategy for Serotonin Recognition

, 2022
A novel electrochemical sensor was constructed based on an enzyme-mediated physiological reaction between neurotransmitter serotonin per-oxidation to reconstruct dual-molecule 4,4′-dimeric-serotonin self-assembled derivative, and the potential biomedical
Min-Ho Lee (1567513), Sachin Ganpat Chavan (6576569), Ajay Kumar Yagati (1561576), Sangho Yeon (14161108), Taek Lee (1561579), Anna Go (14161105), Aneesh Koyappayil (14161102)   +6 more
core   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

FEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Procarbazine and antidepressants: a retrospective review of the risk of serotonin toxicity [PDF]

, 2014
Background Procarbazine is an anticancer agent that also inhibits monoamine oxidase, an enzyme responsible for the metabolism of various catecholamines, including serotonin.
Baker, Nicole M., Kraft, Shawna L., Carpenter, Julia, Bostwick, Jolene R.   +3 more
core   +1 more source